| 
								 
								Dear Friends,
								 
								
								The rising cost of prescription drugs has forced the federal government to enact 
								legislation to address this problem. The Medicare Prescription Drug Discount Card 
								Program was signed into law in 2003, but is not slated to take full effect until 2006. 
								However, New York seniors, age 65 and over, have been able to take advantage of 
								EPIC, the Elderly Pharmaceutical Insurance Coverage Program, since October 1987. 
								EPIC provides prescription drug coverage to over 330,000 seniors with incomes of up 
								to $35,000 for individuals and $50,000 for married couples. 
								 
								
								Under the new federal legislation, Medicare drug benefits will offer another choice to 
								EPIC enrollees. Seniors will also be able to choose between Medicare and EPIC and, 
								in some cases, enroll in both programs to maximize their benefits.
								 
								
								From now until December 2005, seniors enrolled in EPIC can apply for the Medicare 
								interim discount card and its estimated 10 percent to 25 percent discount on prescription 
								drugs. The discount card will also be available to single seniors with an annual income up 
								to $12,569 or a married couple with an annual income up to $16,862. A $600 credit will be 
								provided annually to seniors who qualify.   
								 
								
								Included is an analysis of the potential impact the federal Medicare Prescription Drug 
								Discount Card Program may have on New York’s EPIC Program. This analysis offers 
								suggestions to consumers about anticipated costs, savings and the options available 
								to them. This information is being provided to help you make an informed choice when 
								selecting a prescription drug plan. I hope you find this information useful. If you have any 
								questions, please contact me.
								 
								
									
										 | 
										
										 
										Sincerely, 
										  							
										Michael J. Fitzpatrick
										 
										 | 
									 
								 										
								 |